Inge M. E. Dijkstra
Impact in
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
- Lipid metabolism and biosynthesis
Papers in
-
- Metabolism and Genetic Disorders 10
-
- Peroxisome Proliferator-Activated Receptors 22
- RNA regulation and disease 3
- Co-authors
- Stephan Kemp (22 shared papers)Ronald J. A. Wanders (11 shared papers)Marc Engelen (14 shared papers)Rob Ofman (8 shared papers)Bwee Tien Poll‐The (3 shared papers)Björn M. van Geel (2 shared papers)Arno van Cruchten (1 shared paper)Frédéric Maxime Vaz (6 shared papers)
- Journals
- Journal of Inherited Metabolic Disease (4 papers)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2 papers)Frontiers in Cell and Developmental Biology (2 papers)Molecular Genetics and Metabolism (2 papers)PLoS ONE (2 papers)
- Partner nations
- NetherlandsUnited StatesAustria
In The Last Decade
Inge M. E. Dijkstra
25 papers receiving 862 citations
Peers
Comparison fields: 5 of 62
- Clinical Biochemistry 257
- Biochemistry 107
- Molecular Biology 735
- Physiology 238
- Physiology 36
Countries citing papers authored by Inge M. E. Dijkstra
This map shows the geographic impact of Inge M. E. Dijkstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge M. E. Dijkstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge M. E. Dijkstra more than expected).
Fields of papers citing papers by Inge M. E. Dijkstra
This network shows the impact of papers produced by Inge M. E. Dijkstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge M. E. Dijkstra. The network helps show where Inge M. E. Dijkstra may publish in the future.
Co-authors
The 25 scholars most cited alongside Inge M. E. Dijkstra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 182 | |
| 2 | 2010 | 139 | |
| 3 | 2017 | 58 | |
| 4 | 2020 | 55 | |
| 5 | 2020 | 49 | |
| 6 | 2012 | 41 | |
| 7 | 2017 | 40 | |
| 8 | 2016 | 40 | |
| 9 | 2018 | 35 | |
| 10 | 2014 | 33 | |
| 11 | 2021 | 31 | |
| 12 | 2022 | 30 | |
| 13 | 2022 | 24 | |
| 14 | 2012 | 23 | |
| 15 | 2024 | 22 | |
| 16 | 2016 | 16 | |
| 17 | 2017 | 15 | |
| 18 | 2016 | 14 | |
| 19 | 2021 | 11 | |
| 20 | The long-acting GLP-1 analogue, liraglutide, increases beta cell numbers during early human development | 2005 | 6 |
About Inge M. E. Dijkstra
Inge M. E. Dijkstra is a scholar working on Clinical Biochemistry, Molecular Biology, Physiology, Biochemistry and Genetics, having authored 26 papers that have together received 877 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (22 papers), Metabolism and Genetic Disorders (10 papers), Adipose Tissue and Metabolism (8 papers), RNA regulation and disease (3 papers), Lipid metabolism and biosynthesis (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Virus-based gene therapy research (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Clinical Biochemistry (257 citations), Biochemistry (107 citations), Molecular Biology (735 citations), Physiology (238 citations) and Physiology (36 citations). Inge M. E. Dijkstra has collaborated with scholars based in Netherlands, United States and Austria. Frequent co-authors include Stephan Kemp, Ronald J. A. Wanders, Marc Engelen, Rob Ofman, Bwee Tien Poll‐The, Björn M. van Geel, Arno van Cruchten, Frédéric Maxime Vaz, Marjolein Turkenburg and Carlo W.T. van Roermund. Their work appears in journals such as Journal of Inherited Metabolic Disease, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Frontiers in Cell and Developmental Biology, Molecular Genetics and Metabolism and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.